169 related articles for article (PubMed ID: 23554530)
1. Mitigating the risk of HIV infection with opioid substitution treatment.
Gowing LR; Hickman M; Degenhardt L
Bull World Health Organ; 2013 Feb; 91(2):148-9. PubMed ID: 23554530
[No Abstract] [Full Text] [Related]
2. Opioid treatment in Ukraine risks losing momentum.
Bull World Health Organ; 2013 Feb; 91(2):87-8. PubMed ID: 23554519
[TBL] [Abstract][Full Text] [Related]
3. Opioid substitution: improving cost-efficiency.
Sullivan S
Bull World Health Organ; 2013 Feb; 91(2):83. PubMed ID: 23554517
[No Abstract] [Full Text] [Related]
4. Scaling up opioid dependence treatment in low- and middle-income settings.
Wu Z; Clark N
Bull World Health Organ; 2013 Feb; 91(2):82-82A. PubMed ID: 23554516
[No Abstract] [Full Text] [Related]
5. [The risk behavior of drug addicts requires holistic approach from the society. Syringe exchange and methadone-/buprenorphine treatment are important elements].
Håkansson AC
Lakartidningen; 2012 Jun 19-26; 109(25):1216-7. PubMed ID: 22838110
[No Abstract] [Full Text] [Related]
6. Delivery models of opioid agonist maintenance treatment in South Asia: a good beginning.
Rao R; Agrawal A; Kishore K; Ambekar A
Bull World Health Organ; 2013 Feb; 91(2):150-3. PubMed ID: 23554531
[No Abstract] [Full Text] [Related]
7. Risk dimensions of HIV-tested substance users.
Ottomanelli G
Int J Addict; 1993 Dec; 28(14):1487-95. PubMed ID: 8307661
[TBL] [Abstract][Full Text] [Related]
8. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.
Lambers FA; Stolte IG; van den Berg CH; Coutinho RA; Prins M
Int J Drug Policy; 2011 May; 22(3):210-8. PubMed ID: 21392958
[TBL] [Abstract][Full Text] [Related]
9. Law enforcement and drug treatment: a culture clash.
Cohen J
Science; 2010 Jul; 329(5988):169. PubMed ID: 20616266
[No Abstract] [Full Text] [Related]
10. Scale-up of opioid substitution therapy in India: opportunities and challenges.
Kumar MS; Agrawal A
Int J Drug Policy; 2012 Mar; 23(2):169-70. PubMed ID: 22280919
[No Abstract] [Full Text] [Related]
11. Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission.
Bachireddy C; Weisberg DF; Altice FL
Addiction; 2015 Dec; 110(12):1869-71. PubMed ID: 26464200
[No Abstract] [Full Text] [Related]
12. No opiate substitutes for the masses of IDUs.
Cohen J
Science; 2010 Jul; 329(5988):165-7. PubMed ID: 20616264
[No Abstract] [Full Text] [Related]
13. Putting risk compensation to rest: reframing the relationship between risk behavior and antiretroviral therapy among injection drug users.
Marshall BD; Wood E
AIDS; 2012 Nov; 26(18):2405-7. PubMed ID: 23151496
[No Abstract] [Full Text] [Related]
14. HIV seroconversion and risk factors among drug users receiving methadone maintenance treatment in China: A qualitative study.
Wang C; Shi CX; Zhang B; Chen H; Wang H; Zhang N; Rou K; Cao X; Luo W; Wu Z
Drug Alcohol Depend; 2016 Oct; 167():169-74. PubMed ID: 27567967
[TBL] [Abstract][Full Text] [Related]
15. Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.
Gonzalez A; Mimiaga MJ; Israel J; Andres Bedoya C; Safren SA
AIDS Behav; 2013 Jan; 17(1):168-73. PubMed ID: 23008124
[TBL] [Abstract][Full Text] [Related]
16. Crack cocaine use in a cohort of methadone maintenance patients.
Des Jarlais DC; Wenston J; Friedman SR; Sotheran JL; Maslansky R; Marmor M
J Subst Abuse Treat; 1992; 9(4):319-25. PubMed ID: 1479629
[TBL] [Abstract][Full Text] [Related]
17. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
Farnia M; Ebrahimi B; Shams A; Zamani S
Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
[TBL] [Abstract][Full Text] [Related]
18. New treatment gives hope to East Africa's drug users.
Bull World Health Organ; 2013 Feb; 91(2):89-90. PubMed ID: 23554520
[TBL] [Abstract][Full Text] [Related]
19. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
[TBL] [Abstract][Full Text] [Related]
20. [Do we need a methadone maintenance program?].
Täschner KL
Nervenarzt; 1991 Sep; 62(9):524-8. PubMed ID: 1956471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
